Adial director granted 9,185 stock options
ADIAL PHARMACEUTICALS, INC. director Anderson J. Kermit received a grant of stock options covering 9,185 shares of common stock at an exercise price of $1.64 per share.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
ADIAL PHARMACEUTICALS, INC. director Anderson J. Kermit received a grant of stock options covering 9,185 shares of common stock at an exercise price of $1.64 per share. The options expire on April 6, 2036 and fully vest on the earlier of one year from grant or a Change of Control, subject to his continued service. Following this grant, he holds 9,185 options directly.
Insider Trade Summary
Grant/Award: 9,185 shares
Grant/Award
1 txn
Insider
Anderson J. Kermit
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 9,185 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 9,185 contracts (Direct)
Footnotes (1)
- F1. The option vests in full on the earlier of (i) the one-year anniversary of the grant date; or (ii) a Change of Control (as defined in the Issuer's 2017 Equity Incentive Plan, as amended), subject to the Reporting Person's continued service to the Issuer through the vesting date.
Key Figures
Options granted: 9,185 options
Exercise price: $1.64 per share
Underlying shares: 9,185 shares
+2 more
5 metrics
Options granted
9,185 options
Grant to director on April 7, 2026
Exercise price
$1.64 per share
Stock option strike price
Underlying shares
9,185 shares
Common stock underlying the option
Total options after grant
9,185 options
Held directly following transaction
Option expiration
April 6, 2036
Final date to exercise the options
Key Terms
Stock Option (Right to Buy), Change of Control, 2017 Equity Incentive Plan, exercise price, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
Change of Control financial
"earlier of (i) the one-year anniversary ... or (ii) a Change of Control"
A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.
2017 Equity Incentive Plan financial
"Change of Control (as defined in the Issuer's 2017 Equity Incentive Plan, as amended)"
exercise price financial
"conversion_or_exercise_price: "1.6400""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ADIL director Anderson J. Kermit report?
He reported receiving a grant of stock options for 9,185 shares of Adial Pharmaceuticals common stock. The options are a compensation-related award, not an open-market purchase, and give him the right to buy shares at a fixed exercise price if they vest.
What is the exercise price of the new ADIL stock options?
The stock options have an exercise price of $1.64 per share. This is the price at which Anderson J. Kermit can buy Adial Pharmaceuticals common stock once the options vest and before they expire, if he chooses to exercise them.
When do Anderson J. Kermit’s ADIL options vest?
The options vest in full on the earlier of the one-year anniversary of the grant date or a Change of Control. Vesting is conditioned on his continued service with Adial Pharmaceuticals through the applicable vesting date, according to the equity incentive plan terms.
When do the newly granted ADIL stock options expire?
The options expire on April 6, 2036 if not exercised earlier. After this expiration date, Anderson J. Kermit would no longer be able to purchase Adial Pharmaceuticals common stock under this particular option award.
How many ADIL options does Anderson J. Kermit hold after this grant?
After the reported grant, he holds 9,185 stock options directly. Each option relates to one share of Adial Pharmaceuticals common stock, subject to the vesting and exercise terms described in the award and the company’s equity incentive plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
